By Drug Target Review2025-01-13T08:00:55
Learn how Kindeva and Emervax are advancing vaccine delivery with painless, needle-free technology designed to improve accessibility and uptake worldwide.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-03-07T10:55:58
Sponsored by Agilent
2023-03-30T09:15:30
Sponsored by Halo Labs
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-02-13T11:57:11
Sponsored by Agilent
Site powered by Webvision Cloud